The Challenges of Measuring Tumor Heterogeneity

Video

Ari Melnick, MD, a professor of medicine at the Weill Cornell Medical College, discusses the challenges associated with measuring tumor heterogeneity.

Clinical Pearls

Ari Melnick, MD, a professor of medicine at the Weill Cornell Medical College, discusses the challenges associated with measuring tumor heterogeneity.

  • Measuring variability requires looking at many methylated sites in the genome, which is unlikely to become a routine test
  • There remains a need for a way to measure tumor heterogeneity in a reliable and meaningful way
  • Researchers are currently looking for si​tes in the genome that may be a surrogate marker for genome-wide profiling
  • It is impossible to target diversity from the genetic standpoint, though epigenetic diversity could be targeted
  • Hypothetically, drugs could demethylate the genome to make it more uniform
Related Videos
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
Related Content